Category: New products
-
Trial Underway of AI Depression Guidance System
A clinical trial has begun testing a system based on artificial intelligence to help clinicians prescribe personalized care for depression in patients.
-
Walgreens to Aid Recruitment for Clinical Trials
A retail drugstore chain is offering its store locations and online facilities to help recruit a more diverse patient population for clinical trials.
-
Digital Biomarkers Reveal Alzheimer’s Gender Differences
A study of people with and without Alzheimer’s disease found differences between women and men in their state of cognitive decline with data from mobile devices.
-
Mobile Therapy Shown to Cut Opioid Hospital Care
An analysis of insurance claims shows patients using a mobile therapy app for opioid addiction use fewer hospital services than similar individuals without the app.
-
Companies Partner on Optimal Parkinson’s Drug Delivery
Two companies are developing a system to identify optimal times for people with Parkinson’s disease to take their symptom-reducing medications.
-
Sites Revealed for Lung Cancer Precision Diagnostic Trial
The first sites are selected for a study testing people with suspected lung tumors for cancer-causing mutations, to help decide on personalized treatments for their disease.
-
Trial Demonstrates 3-D Printed Ear Tissue Implant
A patient in a clinical trial received an implant made of three-dimensional printed tissue to replace a deformed ear caused by microtia, a congenital condition.
-
Challenge Seeks Tech, Models to Reduce Stillbirths
A research competition is seeking better technologies to measure gestational development and predict outcomes to reduce the number of stillbirths by half.
-
GSK Acquires Advanced Vaccine Biotech in $3.3B Deal
Drug maker GSK is buying a biotechnology company developing vaccines for respiratory and infectious diseases that generate multiple immune responses.
-
Grant Funds Epilepsy Stem Cell Therapy Trial
A developer of stem cell therapies for neurological disorders is receiving an $8 million grant to advance a treatment for a common type of epilepsy.